MarketsandMarkets Single-Cell Analysis Conference- London

Over last several years, there has been a rapid development of technologies, methods, and applications of Single-Cell Analysis. Recent advances in single cell technologies have opened new avenues to signify the intra-tumor cell heterogeneity, identify rare cell kinds, degree of mutation, and ultimately guide diagnosis and treatment option. Single-cell sequencing is one of the most promising methods to study the tumor cells in cancer progression. These technologies have progressed intensely, and vigorously over the past five years.

Our MarketsandMarkets Single-Cell Analysis Conference UK/EU Edition is scheduled to be held on 6th-7th October 2022 in London, UK aims to bring together the Researchers, Scientists from top universities and pharmaceutical companies from all around the globe to address the recent developments and challenges in analyzing single cell and provides the platform to share the knowledge with academic peers and present their research papers and report

Key Highlights:

• Secretion based Single Cell Analysis and Sorting
• Cyto-Mine® - A Robust and Easy-To-Use Fully Integrated Microfluidic Platform for Biologics Discovery
• Protein Quantification from a Single Cell Using TMTpro™ Mass Spectrometry
• Single-Cell RNA Profiling Without Microfluidics
• Using NGS - Single Cell Data Analysis of the Human Endometrium
• Safety of Cell Therapy Products: In vitro Methods to Assess the Tumorigenicity of Human Cell-Based Therapeutic Products
• Preimplantation Genetic Testing
• Dissecting Pathological Phenotypes in Covid-19 Lung Tissue Using Integrated Single Cell and Spatial Transcriptomics
• An Unsupervised Linear Clustering Algorithm to Improve Identification of Pathogenic Mutations
• Microfluidics Devices for Diagnostics, Drug Screening and Delivery of Biologics
• Single Cell Whole Genome Sequencing of Human Brain Cells for Somatic Cnvs
• Scale-Up Based on a Direct Comparison of Small- and Large-Scale Reactors by Advanced First Principal Simulations
• Innovation in CRISPR Gene Editing: New Avenues for Gene Therapy
• Using Single-Cell Spatial Transcriptomic to Study Neuronal Subtypes in The Brain

Confirmed Speakers:

• Francesco Mazzarotto, Department of Molecular and Translational Medicine, University of Brescia, Italy
• Rick Kamps, Head Research Engineer in the Department of Toxicogenomics, Maastricht University
• Ian Pike, Chief Scientific Officer, Proteome Sciences
• Nicolas Fernandez, Senior R&D Project Leader, Scipio Bioscience
• Frank Gesellchen, Principal Scientist, Sphere Fluidics Limited
• Guruviknesh Sathyanarayanan, Genetic technologist, Oncologica UK
• Christos Proukakis, Professor of Neurology and Neurogenetics, UCL Queen Square Institute of Neurology
• Alain Wagner, Co-founder, MicroOmiX Tech
• Senior Representative, TBA, Parse Biosciences
• Joanna Jackow, Lecturer, Kings College London
• Christian Witz, Senior Scientist, Research Center Pharmaceutical Engineering GmbH
• Marianne Henry, Senior Scientist, Cell and Gene Therapy Catapult
• Jimmy Lee, Data scientist (Computational), Wellcome Sanger Institute
• Stéphane Bugeon, Researcher, UCL
• Darren Griffin, Professor of Genetics |Director, Centre for Interdisciplinary Studies of Reproduction, University of Kent
• Dimitrios A. Lamprou, Chair, UKICRS (UK and Ireland Controlled Release Society)
• Wilfred van IJcken, CO-FOUNDER, Methylomics
• Melanie Bailey, Professor, University of Surrey